Dr. André T. Dahinden, General Manager of Amgen Switzerland, talks about their four cutting-edge products that will help drive future growth, reveals…

Established in November 2014, Amgen’s Next-Generation Biomanufacturing facility in Singapore heralds a new juncture of efficient and innovative…

With Amgen having recently reacquired the sales rights to three of its drugs, the company’s GM in Singapore and Malaysia, Raphael Ho, explains the…

Francesco di Marco, General Manager for Amgen Italy, shares his view on the state of the Italian pharmaceutical sector, the turnaround the company has…

Amgen Netherlands is preparing to launch five new products next year, including their leading cardiovascular biotech product Repatha and recently…

One of the new generation of pharmaceutical general managers in Romania discusses the complexities of introducing innovative therapies on the market…

The executive director and general manager of Amgen Mexico discusses how the company relies on Mexico as a hub for clinical research, with an…

The executive director and general manager of Amgen Mexico discusses how the company relies on Mexico as a hub for clinical research, with an…

Roland Wandeler, general manager of Amgen Iberia, discusses the affiliate’s commitment to innovation, clinical trials, and the importance of…

Roland Wandeler, general manager of Amgen Iberia, discusses the affiliate’s commitment to innovation, clinical trials, and the importance of…

Ramón Palou de Comasema, Country Director of Amgen Portugal, talks about the struggle to enter the reimbursement process in Portugal, how Amgen…

Ashraf Allam, Regional Managing Director of Amgen, talks about the main challenges the company has faced, the benefit of building a company in the…